Fig. 6From: Complete response to combination therapy using nivolumab and ipilimumab for metastatic, sarcomatoid collecting duct carcinoma presenting with high expression of programmed death-ligand 1: a case reportMetastatic lesions (yellow arrows) a immediately and b at 20 months after the administration of nivolumab and ipilimumabBack to article page